Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medication
FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medication
FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medication
Submitted by
admin
on October 5, 2009 - 3:00pm
Source:
Yahoo/AP
News Tags:
FDA
Schering Plough
skin cancer
PegIntron
Headline:
FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medication
Do Not Allow Advertisers to Use My Personal information
